Oncology Research (OR)

Oncology Research is committed to publishing high-quality, innovative research that is focused on the entire range of basic, translational, and clinical cancer research, with a particular interest in cancer therapeutics, providing a new platform for the understanding, prevention, diagnosis, and treatment of cancer. Oncology Research is committed to publishing high-quality, innovative research that is focused on the entire range of basic, translational, and clinical cancer research, with a particular interest in cancer therapeutics. Specific areas of interest include but are not limited to: identification of potential targets for cancers and the exploration of novel molecular mechanisms of tumorigenesis and metastasis; development of novel small molecules and targeted therapies;mechanisms of drug sensitivity; mechanisms of cellular drug resistance; biomarkers of response and/or resistance; novel experimental model systems and technologies relating to cancer therapeutics; pharmacogenetics and pharmacogenomics; personalized medicine; cancer stem cell; immunotherapy and clinical immunology; gene therapy; and radiobiology and novel approaches to radiation therapy either alone or in combination with chemotherapy. For studies that investigate the role of non-coding RNAs as regulators of cellular gene expression, it will be important for more in-depth mechanistic studies to be conducted that confirm their biological activity and their potential effect as mediators of chemosensitivity.

Oncology Research (OR) is :-

• International, Peer-Reviewed, Open Access, Refereed, clinical cancer research, clinical immunology, gene therapy, radiobiology, pharmacogenetics, pharmacogenomics, cancer stem cell , Online or Print , Monthly Journal

• UGC Approved, ISSN Approved: P-ISSN P-ISSN: 0965-0407, E-ISSN: 1555-3906, Established: 1993, Impact Factor: 4.1
• Provides Crossref DOI

• Indexed in: Scopus, WoS, PubMed

• Not indexed in DOAJ, UGC CARE